Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 18, 2022 - Issue 3: The JAKi in inflammatory disorders & arthritis: lights and shadows
Submit an article Journal homepage
903
Views
7
CrossRef citations to date
0
Altmetric
Review

Tofacitinib for the treatment of active ankylosing spondylitis in adults

Raagav MohanakrishnanDivision of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USAView further author information
,
Secia BeierDivision of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USAView further author information
&
Atul DeodharDivision of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USACorrespondence[email protected]
View further author information
Pages 273-280 | Received 14 Aug 2021, Accepted 01 Feb 2022, Published online: 21 Feb 2022

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Abdelmoujoud Faris, Hanine Hadni, Basil A. Saleh, Hadjer Khelfaoui, Dalal Harkati, Hassan Ait Ahsaine, Menana Elhallaoui & Gamal A. El-Hiti. (2023) In silico screening of a series of 1,6-disubstituted 1H-pyrazolo[3,4-d]pyrimidines as potential selective inhibitors of the Janus kinase 3. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now

Articles from other publishers (6)

Nem Kumar Jain, Mukul Tailang, Hemant Kumar Jain, Balakumar Chandrasekaran, Biswa Mohan Sahoo, Anandhalakshmi Subramanian, Neelaveni Thangavel, Afaf Aldahish, Kumarappan Chidambaram, M. Alagusundaram, Santosh Kumar & Palani Selvam. (2023) Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review. Frontiers in Pharmacology 14.
Crossref
Sunghark Kwon. (2022) Molecular dissection of Janus kinases as drug targets for inflammatory diseases. Frontiers in Immunology 13.
Crossref
Sung Hun Bae, Hyeon Gyeom Choi, So Yeon Park, Sun-Young Chang, Hyoungsu Kim & So Hee Kim. (2022) Effects of Isosakuranetin on Pharmacokinetic Changes of Tofacitinib in Rats with N-Dimethylnitrosamine-Induced Liver Cirrhosis. Pharmaceutics 14:12, pages 2684.
Crossref
Robert RoskoskiJr.Jr.. (2022) Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders. Pharmacological Research 183, pages 106362.
Crossref
Marcus Kenyon, Sinead Maguire, Anna Rueda Pujol, Finbar O’Shea & Ross McManus. (2022) The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease. Rheumatology International 42:12, pages 2085-2095.
Crossref
Ahmed M. Shawky, Faisal A. Almalki, Ashraf N. Abdalla, Ahmed H. Abdelazeem & Ahmed M. Gouda. (2022) A Comprehensive Overview of Globally Approved JAK Inhibitors. Pharmaceutics 14:5, pages 1001.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.